SCHEMBL9325219

SCHEMBL9325219

Cc1ccc(/C=N\C2C3CCN(CC3)C2C(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 16/20 0.52
ACHE P22303 1/20 0.44
BACE1 P56817 1/20 0.44
BCHE P06276 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9325208 1.00 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9325229 1.00 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9325214 1.00 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9322749 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9324137 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9324143 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9324119 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9322753 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9322742 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9324127 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0409931-B1 QUINUCLIDINE THERAPEUTIC AGENTS PFIZER (US) 1994-02-16 EP disclosed
US-5162339-A Substance P Antagonists, Gastrointestinal and Central Nervous System Disorders, Antiinflammatory Agents, Analgesics PFIZER INC. (US) 1992-11-10 US disclosed
WO-1990005525-A1 QUINUCLIDINE DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1990-05-31 WO disclosed